Novartis Splits Chair and CEO Positions, Names Joe Jimenez CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
The news eclipses reports of a strong 2009, in which Novartis received 30 major regulatory approvals, and saw sales grow across major divisions